Stocks making the biggest moves midday(2):

$Bank of America (BAC.US)$
– The bank stock was about flat even after the firm reported first-quarter earnings and revenue that topped expectations. Its strong results were driven by higher rates as net interest income jumped 25% year over year. CEO Brian Moynihan said he sees a relatively mild recession in the U.S.
$Bank of New York Mellon (BK.US)$
– The bank’s shares dropped 0.3% after a mixed first-quarter earnings report. While the bank’s earnings came in line with Wall Street’s estimates, its revenue came in below expectations. The company posted $4.36 billion in revenue, compared to the $4.40 billion anticipated by Wall Street, according to Refinitiv.
$Goldman Sachs (GS.US)$
– Shares slid 1.3% after Goldman Sachs reported first-quarter revenue of $12.22 billion, lower than the $12.79 billion forecasted by analysts polled by Refinitiv. The investment bank also reported a $470 million hit tied to a partial sale of its Marcus loans portfolio.
$Johnson & Johnson (JNJ.US)$
– Shares of the health-care products company declined 2.7% despite reporting an earnings and revenue beat for the first quarter. The company reported adjusted earnings of $2.68 per share and revenue of $24.75 billion. Analysts polled by Refinitiv had estimated per-share earnings of $2.50 and $23.67 billion in revenue. The company reported a net loss of $68 million, or 3 cents per share, stemming from its talc-based baby powder troubles and costs from its upcoming spin-off of its consumer health business.
$Southwest Airlines (LUV.US)$
– Shares of the airline fell more than 1% after computer issues on Tuesday led Southwest to ground flights around the country. At least 1,500 flights, or 36% of Southwest’s schedule, were delayed, according to flight-tracking site FlightAware.
$BELLUS Health (BLU.US)$
– Bellus shares roughly doubled after GSK said it would acquire Canada-based biopharmaceutical company Bellus. Bellus’s stock jumped 98%; the U.S.-listed shares of GSK dipped 1.6%.